Discussion
The present study suggests that blue light may be toxic for human ocular surface cells, as demonstrated by the in vitro culture study in which the toxic effect of blue light was alleviated to a greater or lesser extent by shades that blocked light around 400–450 nm. When the blue-plus-blocking shade was used, it attenuated the toxic effect more prominently than did the violet-blocking shade. Since the blue-plus-blocking shade blocks visible blue light around 400–450 nm more effectively than the violet-blocking shade, it is strongly suggestive of blue light being a toxic agent to ocular cells. This study is the first to investigate the protective effect of light-blocking shades against blue light phototoxicity in human ocular surface cells, and these results are consistent with previous investigations with retinal cells.13 14
Ant-pan keratin antibody used in the present study was immunoreactive with AE1/A3 that is a group of keratin filaments with both low and high molecular weights, and the keratin is expressed in epithelial cells.32 However, the microscopic images showed that fibroblast-like cells found in cultured cells were keratin negative. Regarding the reason why keratin was not detected in all the cultured cells, it is considered that bFGF in the culture medium mediated epithelial mesenchymal transformation (EMT) as reviewed by Lee et al.33 It was reported that adult human corneal epithelial cells (HCEC) are mitotically inactive and are arrested at the G1 phase of the cell cycle.34 However, when cornea is injured, HCECs could resume proliferation and alter their cell morphology known as EMT, and in vitro studies revealed that EMT is mediated by bFGF.35 36 As such, it is suggested that bFGF supplemented in the medium induced EMT in the present study. In addition to EMT, contamination of fibroblasts derived from corneal keratocytes may need to be considered. Corneal keratocytes residing in stroma are quiescent cells. Once injury or infection occurs, these cells lose their quiescent state and acquire activated phenotypes that have the properties of fibroblasts and myofibroblasts.37–39 It was reported that keratocytes can be activated in vitro by growth factors such as transforming growth factor-β, platelet-derived growth factor and bFGF.40–42 Accordingly, a possibility that some corneal keratocytes contaminated in the cell culture proliferated in the presence of bFGF could not be excluded in the present study.
Even under the in vitro conditions where some tested cells exhibited fibroblastic feature and they were regarded as a mixed population of keratinocyte and fibroblast-like cells, the present study suggests that blue light may be toxic for human ocular surface cells, as demonstrated by the in vitro culture study in which the toxic effect of blue light was alleviated to a greater or lesser extent by shades that blocked light around 400–450 nm.
Regarding the underlying mechanism by which blue light induces a toxic effect on ocular cells, reactive oxygen species (ROS) has been suggested to be involved.9–11 That is, exposure to blue light provokes ROS overproduction via mitochondrial damage. Since it was reported that the absorption spectrum of a whole mitochondrial suspension in a reduced state gives a peak between 400 and 450 nm,43 405 nm blue light could be absorbed by mitochondria. Thus, to confirm the involvement of ROS, the ameliorating effect of ROS-specific scavengers on the phototoxic effect should be examined following identification of ROS in the near future.
We speculate that long-term exposure to blue light from portable devices emitting blue light from a short distance may cause potential damage to ocular health, especially in high-risk populations,11 44 such as people with DED, contact lens users, the malnourished and the elderly, due to accumulated oxidative stress that is a result of an imbalance between ROS generation and scavenging.
Oxidative stress evoked by blue light exacerbates DED as suggested in previous investigations.45–48 This could become a common health problem since office workers in modern society are at risk of DED.49 In addition, blue light could aggravate the DED-related visual symptoms, such as blurred retinal images caused by increased scattering at the ocular surface due to an unstable tear film.6 7 Additionally, patients with DED may have dermatologic (eg, rosacea, scleroderma)50 and systemic problems (eg, rheumatological diseases) that are not yet diagnosed. Some of them may have light sensitivity and need to be careful of light exposure. Besides DED and its related symptoms, there are a number of unsolved issues related to artificial blue light-induced cellular damage associated with the ocular surface and macula.5 The sunlight spectrum is a uniformly distributed wavelength and its energy is simply dose dependent. By contrast, the modern lighting environment is rapidly changing, and it is made up of different artificial instruments producing a spectral imbalance. Although no report has documented chronic ocular damage from ambient fluorescent or incandescent light, we propose that photoprotective measures from ambient lighting conditions should be established.
The limitations of the present study are summarised below. EMT was induced probably by bFGF in the present study, indicating that effects on untransformed HCECs were not completely evaluated. In addition, this is an in vitro cell culture study and should be further confirmed with clinical or animal studies. Only acute phototoxicity was examined in the present study and a long-term study may be better to evaluate tissue damage after accumulated toxicity. Various other light spectra should also be examined, including green, yellow and red lights as these are included in the daily environment.
In conclusion, the present results indicate that blue light injures human ocular surface cells and the cells are protected from damage by a shade. Blue light protection may be recommended for high-risk populations.